Description
IGF::OT::IGF XYREM MEDICATION
First action · last action
2014-03-19 · 2014-05-09
Transactions
3
First transaction's obligation
$27,810
Base + all options value (sum of deltas)
$64,890
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797BP0419
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-03-19+$27,810= $27,810
- Mod P000012014-04-01+$37,080= $64,890
- Mod P000022014-05-09+$0= $64,890
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-03-19 | +$27,810 | $27,810 | IGF::OT::IGF XYREM MEDICATION |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-04-01 | +$37,080 | $64,890 | IGF::OT::IGF XYREM MEDICATION |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-05-09 | +$0 | $64,890 | IGF::OT::IGF XYREM MEDICATION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H9AXCNRA5NE6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0282 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $14,672 | FY2026 |
| 36C26026F0146 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $397,859 | FY2026 |
| 36C24526N0198 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $14,243 | FY2026 |
| 36C26026F0012 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $133,028 | FY2026 |
| 36C26026F0013 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $231,127 | FY2026 |
| 36C26026F0027 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under R499 from 246-NETWORK CONTRACTING OFFICE 6 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24616P1889 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS INC | 246-NETWORK CONTRACTING OFFICE 6 | $4,900 | FY2016 |
| VA24615P6478 | HPP WESTERN, LLC | 246-NETWORK CONTRACTING OFFICE 6 | $5,975 | FY2016 |
| VA24615P7733 | TELLER, JEFFERSON H | 246-NETWORK CONTRACTING OFFICE 6 | $4,680 | FY2016 |
| VA24615P8535 | HALL, ELSIE | 246-NETWORK CONTRACTING OFFICE 6 | $5,700 | FY2016 |
| VA24615F6727 | ALVAREZ LLC | 246-NETWORK CONTRACTING OFFICE 6 | $20,887 | FY2015 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24614J3280_3600_VA797BP0419_3600 · retrieved 2026-09-26.